Related Experiment Video

Updated: Jan 2, 2026

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram
06:12

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram

Published on: March 13, 2018

11.0K

Reply to "Viability of electro-oculogram signal processing for diagnosing myasthenia remains elusive"

Mark I Boulos1, Timothy Liang2, Brian J Murray3

  • 1Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Room A4 55, Toronto, ON M4N 3M5, Canada.

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|December 3, 2019
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Acquisition and Semi-Automated Analysis of Respiratory Muscle Surface Electromyography09:42

Acquisition and Semi-Automated Analysis of Respiratory Muscle Surface Electromyography

Published on: January 24, 2025

1.2K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.7K

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K